Key Details
Price
$231.67Last Dividend
$0.53Annual ROE
22.70%Beta
0.93Events Calendar
Next earnings date:
Jan 24, 2025Recent quarterly earnings:
Oct 24, 2024Recent annual earnings:
Aug 01, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 07, 2024Next split:
N/ARecent split:
Aug 31, 2010Analyst ratings
Recent major analysts updates
Screeners with RMD included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
RMD's stock has increased due to strong sales of masks and devices. However, the difficult economic situation is worrying.
ResMed (RMD) has a strong track record of surprising with its earnings and currently has the right mix of factors that suggest it may exceed expectations in its upcoming quarterly report.
No matter if you invest in value, growth, or momentum stocks, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key features of the Zacks Premium research service.
On Monday, December 23, 2024, the S&P 500 rose by 0.7%, with technology stocks performing particularly well as the holiday week began.
On Monday, the stock prices of ResMed (RMD) and Inspire Medical Systems (INSP) dropped as these companies, which create products for sleep apnea, encountered a new challenge from weight-loss medications.
ResMed (RMD) is likely to do better than the market because it shows stronger financial growth compared to others.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons why you should make use of this tool.
Investors who focus on Medical - Products stocks probably know about ResMed (RMD) and Insulet (PODD). However, which of these two companies is the better choice for those seeking undervalued stocks?
This Industry Outlook article has featured ResMed, Haemonetics, Phibro, and Agios.
The increasing need for medical procedures and efforts to reduce costs are expected to benefit the Zacks Medical-Products industry. Companies like RMD, HAE, PAHC, and AGIO are likely to take advantage of these positive trends.
FAQ
- What is the primary business of ResMed?
- What is the ticker symbol for ResMed?
- Does ResMed pay dividends?
- What sector is ResMed in?
- What industry is ResMed in?
- What country is ResMed based in?
- When did ResMed go public?
- Is ResMed in the S&P 500?
- Is ResMed in the NASDAQ 100?
- Is ResMed in the Dow Jones?
- When was ResMed's last earnings report?
- When does ResMed report earnings?
- Should I buy ResMed stock now?